4 Results for "

NLRP3-dependent pyroptosis

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "NLRP3-dependent pyroptosis" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-144223
CAS No.: 791840-86-3
Purity:  99.93%
NLRP3-IN-94 is a NLRP3-dependent Pyroptosis inhibitor with an IC50 of 0.2392 μM .
loading...
    loading...
Cat. No.: HY-149478
CAS No.: 2238820-43-2
Purity:  99.54%
JT002 is an orally active and selective NLRP3 inflammasome assembly inhibitor. JT002 reduces NLRP3-dependent proinflammatory cytokine (such as IL-1β, IL-1α, IL-18) production and pyroptosis. JT002 blocks NLRP3 inflammasome complex formation. JT002 reduces airway hyperresponsiveness and airway neutrophilia in mice. JT002 can be used for the study of a variety of inflammatory diseases, such as Muckle-Wells syndrome (MWS) .
loading...
    loading...
Cat. No.: HY-174312
CAS No.: 2922814-85-3
NLRP3-IN-81 (N102) is a BBB-penetrable inhibitor against NLRP3 inflammasome-dependent pyroptosis with an EC50 of 0.029 μM against cell pyroptosis induced by Nigericin (HY-127019). NLRP3-IN-81 potently inhibits NLRP3-dependent activation of caspase-1 and the release of IL-1β. NLRP3-IN-81 disturbs the interaction of NLRP3 with the adaptor protein ASC and inhibits ASC oligomerization. NLRP3-IN-81 can be used for pyroptosis-related diseases research, such as inflammatory bowel diseases and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-144220
CAS No.: 3033386-91-0
NLRP3/AIM2-IN-1 is an NLRP3/AIM2 inhibitor with an IC50 of 3.136 μM against NLRP3-dependent pyroptosis. NLRP3/AIM2-IN-1 inhibits IL-1β secretion triggered by NLRP3 inflammasome activation. NLRP3/AIM2-IN-1 exhibits moderate anti-pyroptotic activity. NLRP3/AIM2-IN-1 does not inhibit NLRC4 inflammasome activation. NLRP3/AIM2-IN-1 can be used for studying inflammasome-mediated inflammatory diseases .
loading...
    loading...